Camellia Plc (CAM) — Research Note

Executive summary

Camellia is a UK-listed holding company for ~48,000 hectares of agricultural land across seven countries, producing tea, avocados, macadamia, arable crops and rubber, plus a small UK engineering operation. The five-year operating trajectory has been weak — Group revenue has drifted from £291m (2020) to £268m (FY25) and trading profitability has oscillated around break-even, with FY25 finally showing a £1.0m trading profit after FY24's £5.5m loss as the Value Enhancement Plan (announced May 2025) begins to bite. The single most important point for valuation is the enormous gap between the £154.8m market cap and £133.6m of net cash/treasury deposits/gilts/money market instruments — investors are essentially paying ~£21m of enterprise value for a business with £329m of net assets, including £137m of PP&E and 48k Ha of mature land.

Fair value estimate

Methodology: NAV/sum-of-parts with a structural discount, sanity-checked against the modest earnings power emerging under the VEP. The business has too little reliable earnings to support a multiples or DCF approach.
Inputs: Equity attributable to owners of Camellia at 31 Dec 2025 = £291.6m. Of that, ~£133.6m is liquid (cash, treasury deposits, gilts, money markets), ~£136.9m is PP&E (mostly mature bearer plants on owned land), ~£23m is biological assets, ~£14.6m is listed equity investments. The book is conservatively stated — significant land assets carried at historic cost. UK property disposals (Linton Park + artwork, £14.7m proceeds at £5m profit on disposal — see 2026-05 final results) confirm hidden value.
Discount applied: 35–55% to reflect: (i) sustained trading losses; (ii) commodity tea exposure with no pricing power; (iii) climate, weather and political risk in operating jurisdictions; (iv) the long road to deliver £35m of incremental VEP revenue by 2034 2026-05 final results.
Fair value range: 5,000p – 6,700p per share (implied market cap £131m – £176m).
Compared to the current £154.8m mcap (~5,900p/share), this is roughly fair value: ~5–14% downside at the low end, ~+13% upside at the high end. Midpoint ≈ £153m, essentially in line with where the market trades.

Sector context

Sector: Consumer Staples / Food, Beverage & Tobacco — correctly classified.
This is a primary agricultural producer, materially different from packaged food or beverage peers. Quality and growth profile is well below typical Consumer Staples peers (Unilever, Tate & Lyle, Associated British Foods), which earn branded margins. CAM sells largely undifferentiated agricultural commodities. Balance sheet, however, is much stronger than peers (net cash vs. typical 2–3x leverage).
Closest listed comparables: M.P. Evans (UK-listed palm oil producer in Indonesia), R.E.A. Holdings (palm oil). Camellia's tea exposure is more comparable to Indian-listed producers like McLeod Russel or Goodricke (which it controls).

Investment thesis

Deep discount to tangible asset backing. Net cash, treasury deposits, gilts and money market instruments alone (£133.6m) cover ~86% of the £154.8m market cap, with 48k Ha of mature productive land, £137m of PP&E and £290m of net assets attributable to shareholders effectively thrown in for free 2026-05 final results.
VEP early traction. First-year results under the new strategic plan show trading profit improvement of £6.5m (from -£5.5m to +£1.0m), £20m of non-core disposal proceeds delivered in FY25, and four growth projects (Tanzanian avocado, Brazil arable conversion, Brazil citrus, Kenyan blueberry) targeting £35m of incremental revenue by 2034 from £15m of capex — all leveraging existing land and infrastructure 2026-05 final results, 2026-02 trading update.
Capital return discipline. Maintained 260p dividend funded from reserves and completed a £11.6m tender offer plus on-market buyback in 2025, reducing share count from 2.76m to 2.62m, indicating board comfort with balance sheet and willingness to shrink the capital base 2025-09 half year results.

Key risks

Commodity tea is structurally oversupplied. Multiple filings describe a global tea market with rising supply, falling Kenyan demand and Mombasa auction prices grinding down. Bangladesh wages rose 41.7% in 2022 with no offsetting pricing power; Indian wages rose 22.75% in Assam. Margins on tea, the largest crop, look set to remain compressed 2024-04 final results, 2023-05 final results.
Climate and weather concentration risk. Cyclone Freddy hit Malawi macadamia in 2023; severe heat compromised UK apples at Bardsley; "the principal factors are the price of fuel, energy, fertiliser and other agronomic chemicals, the potential for logistics challenges for tea, avocado and macadamia crops from East Africa" given the Iran-Israel conflict noted at the May 2026 results 2026-05 final results.
Geopolitical exposure to fragile jurisdictions. Operations in Bangladesh, Kenya, Malawi, Tanzania face periodic civil unrest, wage interventions, FX shortages, currency devaluations (Malawi Kwacha devalued ~25% in May 2022). The Group has been the subject of historic human-rights litigation against East African operations resulting in significant legal costs in 2020 2022-05 final results.

Operating leverage

Operating leverage at Camellia is low. The cost base is dominated by wages (largest single line, growing faster than revenue in most jurisdictions), fertiliser, fuel, energy and logistics — substantially all of which scale with revenue or production volume rather than being fixed. The tea factories, irrigation infrastructure, packhouses and central admin are the truly fixed elements, but central admin runs at only ~£40m of administrative expenses on £268m of revenue (~15%), and incremental tea volumes carry low contribution margins because per-kilo selling prices have been falling faster than per-kilo input costs in Kenya and Malawi. The clearest "fixed-cost site" examples are the avocado packhouse in Kenya, the Brazilian arable infrastructure (now 60% irrigated, up from 53%) and the new Tanzanian avocado plantation — but these are years from maturity. A 10–20% upside revenue surprise from current run-rate (say to £290–320m) would, generously, add ~£10–15m to trading profit, taking trading profit perhaps to £10–15m. That's meaningful in % terms (a multiple of FY25's £1m) but trivial in absolute £ for a £155m market cap. This is not a name where you buy on the "long-tail upside drops to the bottom line" thesis.

Value-trap signals

Multi-year sequence of trading losses and adjusted PBT losses (FY22, FY23, FY24, FY25 all loss-making after tax from continuing operations).
Reported PBT relies heavily on disposals, impairment reversals and one-offs — earnings quality is poor; cash conversion is weak (cash generated from operations only £10.1m in FY25 against £268m revenue).
Tea, the largest crop, faces structural oversupply with no obvious catalyst for a market rebalance.
Persistently illiquid AIM stock with controlling shareholder (Camellia Holding AG / Camellia Foundation owns 51.67%) — minority shareholders have no governance lever.
Loss-attributable EPS has worsened across the period covered (-181p 2020, -134p 2023, -177p 2024, -187p 2025), suggesting the business is consuming, not creating, per-share value despite the buyback.

Earnings vs. expectations

The filings allow a directional rather than precise read on guidance/consensus tracking. Q1 2024 trading update (Jan 2025) upgraded adjusted losses for FY24 from £7–9m to £4–5m; the actual delivered adjusted loss was £7.0m — a miss versus the upgraded guidance. Sep 2023 trading update flagged adjusted loss before tax of £9–11m for FY23 vs. earlier guidance, and the result came in around £9.3m — broadly met the (already lowered) range. Mar 2023 raised FY22 expectations and the result also broadly met that revised guidance. The earlier Dec 2021 trading update guided to FY21 adjusted PBT of £7–9m and the result came in at £8.8m — met. The pattern: guidance is downgraded repeatedly during the year as conditions disappoint, and the final result then meets or marginally misses the downgraded number. This is a "managing expectations downward" pattern, not a beat-and-raise story.

Conviction

Conviction: 3 (moderate). The NAV anchor is robust — £291.6m of attributable equity, of which £133.6m is liquid and identifiable, is audited and well disclosed. The 47% discount to NAV at which the stock trades is a hard, observable fact. What limits conviction is (i) the operating business genuinely loses money in cash terms, making the discount to NAV partially deserved rather than a pure mispricing, and (ii) the path from £1m of trading profit to anything resembling £20–30m (which would justify a meaningful re-rating) is long, uncertain and weather-dependent. Anchoring factors: clean Deloitte audit, conservative valuation methodology, strong cash position. Limiting factors: opacity on land value, ambiguity on what fraction of the equity book is truly realisable in a wind-down.

Driver scoring & fit for the AI-receiver / operating-leverage / valuation-discipline investor

Camellia is a near-zero AI beneficiary, has limited operating leverage, and although the valuation is genuinely cheap on a NAV basis it does not match the investor's thesis of capturing AI-driven upside.